Silver Book Fact

Pregalbin, an antiepileptic drug, produced around a 32% pain reduction (a significant reduction) at week 16 versus around 20% for placebo, in patients with neuropathic pain due to spinal cord injury.

Cardenas D, Nieshoff E, Suda K, et al. A Randomized Trial of Pregabalin in Patients with Neuropathic Pain due to Spinal Cord Injury. Neurology. 2013; 80(6): 533-9. http://www.neurology.org/content/early/2013/01/23/WNL.0b013e318281546b.abstract

Reference

Title
A Randomized Trial of Pregabalin in Patients with Neuropathic Pain due to Spinal Cord Injury
Publication
Neurology
Publication Date
2013
Authors
Cardenas D, Nieshoff E, Suda K, et al
Volume & Issue
Volume 80, Issue 6
Pages
533-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.  
  • Resolvins, a family of lipid mediators, have shown potential in resolving persistent inflammatory pain.  
  • Advances in neuroimaging will continue to offer information on the brain’s functioning and how it correlates to the pain experience.  
  • Topical capsaicin was found in a meta-analysis to provide a degree of pain relief to some patients with painful neuropathic conditions.  
  • Opioids have been found to reduce pain intensity and improve physical functioning for patients with persistent noncancer pain. It’s important to note that a decrease in mental health functioning…